CELLINK is the final puzzle piece in the 3D Bioprinting industry we all have been waiting for. CELLINK is a bioink that can universally be used on a wide range of 3D Bioprinters. CELLINK can also be used independently of any printing device, in case you want to perform simpler experiments of 3D cell culturing. The unique biocompatibility and printability of our bioink offers outstanding results that will take your research to the next level!
Our laboratory engineers microenvironments to control the fate of cells being used in tissue repair, with the main application being cartilage lesions and microcracks. The approaches include the development of patterned, functionalized hydrogels, mediation of cell-cell and cell-tissue adhesion through nano-coatings and surface treatment, control of inflammation and oxygen tension pathways, and release of cytoskeletal- and Rho GTPase-modifying small molecules to achieve stable phenotypes. Using additive manufacturing (bioprinting), it is possible to combine these tools to generate spatially complex tissues containing multiple cell types and materials. Our goal is the translation of these technologies to the clinics to improve the outcome of current cell-based therapies.
Jon Schull Phd from Rochester Institute of Technology will talk about founding the "Enable Organization", a global network of Passionate Volunteers Using 3d Printing to give prosthetic hands to the Underserved Populations of the World
Jean-Manuel brings more than 20 years of experience in scientific research and medical technology innovation to his work on the Vizua team. While earning his masters degree in neuroscience at Drexel Medical School in Philadelphia, he directed research projects on 3D-reconstruction of neuronal networks and regenerative quantification.
Dr. Baena a bioprinting and orthopedic industry professional. He is founder and CEO of BRECA Health Care and REGEMAT 3D. His work includes professional biomedical engineering and biomechanics, 3D bioprinting, medical devices development, CAD, CFD, FE, creating mathematical models to simulate complex environments and make decisions - Using technology to improve people´s quality of life.
Dr. Shanjani has extensive research experience in system design and development, modeling, testing and utilizing 3D-printing and bioprinting technologies, hardware and software for biomedical, tissue engineering and regenerative medicine applications. He will speak about how 3D printing can be applied to regenerative orthopedics.
The Ourobotics Revolution 3D Bioprinter, is a relatively low-cost machine that can print with 10 materials in the same bioprinted structure (with the potential to add even more). It also includes a heated enclosure and an upgradable and expandable design. Because of its modularity, current applications include everything from human tissue engineering, to pharmaceuticals, food, synthetic biology, electronics, batteries and even textiles.
Plastic surgeon Carrie Stern is the creator of MirrorMe3D, a company which offers 3D printed models to reveal the outcome of breast surgery, or other transformative surgery. By displaying past surgical results in 3D form, patients can gain new insight into the effects of aesthetic surgery.
•Are you looking to deliver your research within Europe?
•Do you need multiple, reliable sites and experienced investigators?
•Do you want to know why you should come to the UK?
In the past the UK’s reputation for delivering clinical research was questionable. But that has all changed. Over the last seven years the research landscape in the UK has improved dramatically allowing the UK to make great strides in delivering research for the Life Sciences industry. So whether you are a Pharmaceutical company, Contract Research Organisation, Biotech, Med Tech or Diagnostic we can help.
The NIHR Clinical Research Network is hosting a live webinar which will explode common myths around the UK’s ability to deliver commercial clinical research. This session will be hosted by Matt Cooper, Business Development and Marketing Director, of the National Institute for Health Research Clinical Research Network (NIHR CRN). It will include performance data that will demonstrate why the UK should be your first choice for clinical research. You can discover:
•How much the UK’s market volume of commercial contract research (supported by the NIHR CRN) has changed and how we recruited more than 34,000 patients to commercial clinical trials in 2014/15
•What percentage of the UK’s National Health Service (NHS) is actively delivering commercial contract research studies (with support from the NIHR CRN)
•The free feasibility service run by the Network
•How to gain access to clinical experts
•What percentage of commercial contract studies (supported by the NIHR CRN) are delivered to time and target
•How we are keeping clinical research in the public eye
•How the UK is sharpening its competitive edge by achieving more and more key first global patient milestones
Jack Ballantyne, Assoc Director; National Center For Forensic Science
The serology-based methods routinely used in forensic casework for the identification of biological fluids have varying and often limited degrees of sensitivity and specificity. A novel strategy for the identification of the body fluid origin of dried forensic biological material (blood, semen, saliva, vaginal secretions and menstrual blood) involves expression profiling of body fluid specific messenger and small RNAs (mRNA and miRNA). RNA analysis may permit not only a molecular-based approach with a greater specificity than that of conventional methodologies for the identification of forensically relevant biological fluids, but may also provide strategies particularly suited for the analysis of environmentally impacted or degraded samples frequently encountered in forensic casework. This presentation will describe highly specific RNA methods for body fluid identification that exhibit promise for forensic casework analysis.
Amarjit Chahal, Senior Director; Warnex Pro-DNA Services, Inc.
The analysis of regular STR DNA has become the “gold standard” of identification in forensic casework. There are numerous cases though where biological evidence exists but regular DNA testing can’t provide probative evidence or insufficient nuclear DNA was obtained. This presentation will describe casework scenarios where miniSTR, Y-STR and/or mtDNA can provide probative evidence.
Brian Zubel: Attorney at Law and Forensic Science Legal Consultant
In February 2009, the National Research Council of the National Academies released its report entitled Strengthening Forensic Science in the United States: A Path Forward. The substantive findings underscore that many traditional forensic disciplines are in scientific crisis, having never been the subject of rigorous validation. This presentation outlines the major findings of the Report, and the impact it will have on the roles of prosecutors, defense attorneys and judges in the rapidly evolving scientific/legal landscape.
Diana Botluk; Director of Research at NCSTL at Stetson Uni. College of Law
This program will explore information and research resources in forensic science, focusing primarily on the resources available from the National Clearinghouse for Science, Technology and the Law at Stetson University College of Law. It will demonstrate features of ncstl.org, such as the free research database, Cold Case Toolkit, Education Center, and other online resources designed to keep you updated with the latest scientific evidence information.
Dr. Thomas R. Bellinger, President of NecroSearch International
This presentation will provide an introduction to NecroSearch International, a non-profit, multi-disciplinary organization dedicated to the location of clandestine graves and evidence. A brief history of NecroSearch will be presented along with a description of the organization's mission (research, training, and investigation) and case acceptance protocol. Several of the organization's expertise categories will be discussed along with a description of NecroSearch's investigative process. The presentation will conclude with a case example.
Amarjit Chahal, Laboratory Director & General Manager at Molecular World Inc
Part of the nuclear DNA that is paternally inherited or passed down from father to son is found on the Y chromosome. Similar to mitochondrial DNA, Y-chromosome testing can be used to distinguish between individuals with different paternal lineages. Short tandem repeats (STR) on Y chromosome are called Y-STRs. Y-STR testing is identical to analyses of nuclear autosomal STR loci. Testing for this type of DNA is particularly useful when mixtures of male DNA (a minor male contributor) and female DNA (predominant female contributor) are suspected or only distant paternal relatives are available for comparisons. The presentation will introduce audience to Y-STR testing with a particular focus on the probative value of Y-STR DNA test reports.
Brian Zubel: Attorney at Law and Forensic Science Legal Consultant
The presentation will begin with a discussion of the effective presentation of DNA evidence in court, including admissibility standards, foundational issues and the limits of argument. Current-generation legal and scientific challenges to DNA will be explored through the review of several recent cases.
Dick Warrington: Crime Scene instructor/Consultant,Lynn Peavey Company
This presentation will show the attendees three methods of lifting developed latent fingerprints off textured surfaces. The three methods that we will talk about are Diff-Lift tape, Mikrosil, and AccuTrans. By using one of these methods demonstrated you’ll be able to lift processed latent fingerprints off a car dash, refrigerators, bank countertops, computers, house siding and a golf ball, just to name a few.
Jack Ballantyne, Assoc Director (Research);National Center For Forensic Science
The development of powerful and robust DNA typing strategies has made it is possible to ascertain with a high degree of certainty whether a biological stain found at a crime scene originated from a particular individual. However, the possibility of obtaining additional information from biological stains exists. For example, the ability to determine the relative time since deposition (TSD) of biological stains could provide law enforcement investigators with novel probative evidence by establishing an approximation of the time of commission of criminal offenses. However, no reliable TSD methods are available at present. We have developed a novel strategy for the determination of the time since deposition of dried bloodstains using spectrophotometric analysis of hemoglobin. An examination of the Soret band in aged bloodstains has revealed a previously unidentified hypsochromic shift (shift to shorter wavelength). The extent of this shift permits a distinction to be made between stains that were deposited minutes, hours, days and months prior to analysis. The effects of temperature and humidity have also been evaluated.
Roger Koppl, Director of the Institute for Forensic Science Administration
The current institutional structure of police forensics gives each lab a monopoly in the analysis of the police evidence it receives.
Forensic scientists have inadequate incentives to produce reliable analyses of police evidence. We should have "competitive self regulation" for police forensics. Each jurisdiction would have several competing forensic labs. Sometimes, evidence would be divided and sent to three separate labs. Chance would determine which labs would receive evidence to analyze. Competitive self regulation improves forensics by creating incentives for error prevention, detection and correction. Surprisingly, it would also reduce the costs of running the criminal justice system.
D. Michael Risinger, John J. Gibbons Professor of Law, Seton Hall University
Domain Irrelevant Information as an Infectious Disease in Forensic Science Practice
In this presentation, Professor Risinger discusses the distorting effects of case information irrelevant to the exercise of one's expertise on the results interpretive processes in forensic science, analogizing such information to an infectious disease. The empirical record bearing on these issues is examined, particularly those empirical results specifically relevant to forensic science practice.
This presentation helps lawyers view complex DNA cases in a new light, while comparing the Duke Lacrosse Case to others. Attorneys do not have to concede when they hear the words "match" or "defendant cannot be excluded". Instead, they should remember that besides standing for deoxyribonucleic acid, DNA also stands for DO NOT ACCEPT at face value. This article looks at the DNA evidence in the Duke Lacrosse case and compares the evidence in that case with DNA evidence in other cases.
This presentation offers practical tips on reviewing complex data generated in DNA cases, discusses the importance of the proper collection and preservation of DNA evidence, discusses the likelihood and ways DNA evidence is subject to contamination, and outlines specific ways to cross-examine DNA experts.
PCR-based DNA tests have greatly improve the capabilities of forensic laboratories. The great successes of these tests have inevitably led to efforts to characterize smaller and smaller amounts of material. As the quantity of DNA template associated with a DNA profile test decreases, the likelihood that the results of the test will be compromised by stochastic effects increases. Questions about the significance of results in such circumstances will be addressed
-- particularly as they pertain to a prominent acquittal in the United Kingdom where low copy number test results played a central role in the prosecution's case.
King Brown and M. Dawn Watkins of the Palm Beach Police Department
The IR-UV camera is a new breakthrough in the forensic field that allows us to drop the background color say a black shirt and show the blood stain patterns, thus allowing for photography, collection testing interpretation of the pattern.
Dr. Amarjit Chahal, Laboratory Director & Technical Leader, Molecular World Inc
Increasing the probative value of degraded or limited DNA evidence by combining two or more DNA technologies: Combining DNA data from all technologies (for example partial nuclear DNA profile, Y-STR profile and mitochondrial DNA profile in case of degraded samples) to increase the probative value of final DNA test report.
Roger Koppl, Institute for Forensic Science Administration Fairleigh Dickinson
The organization of forensic science creates inappropriate biases that will sometimes skew results from the truth. These biases exist even when forensic scientists are perfectly rational and untouched by the sort of psychological infirmities some researchers have emphasized.
Because perfectly rational actors are Bayesian updaters, we may use the term "Bayesian bias" to identify this organizational problem in forensics.